DNA vaccine for Edwardsiella tarda and construction and application thereof
A technology of Edwards tarda, DNA vaccine, applied in Edwards tarda DNA vaccine and its construction and application fields, to achieve the effect of high protection rate and efficient immune protection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0023] The DNA vaccine is shown by the base sequence in the sequence table SEQ ID No.1.
[0024] Construction and preparation method of DNA vaccine:
[0025] 1) Construction of plasmid pPC2: Plasmid pCI-neo (purchased from Promega, USA) was digested with XhoI / SmaI, a 5.4kb fragment was recovered, and the oligonucleotide fragment L86 (5'-TCGAGATATCGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGAGGACCC-3') was digested with T4DNA Ligase ligation, the ligation solution was transformed into E. coli DH5α, and cultured on LB solid medium containing anka penicillin (Ap, 100ug / ml) for 18-24 hours, picked 1 white transformant, and extracted the plasmid, which was pPC2.
[0026] The composition of the LB solid medium is by weight percentage: 1.0% peptone, 0.5% yeast powder, 1.0% sodium chloride, 1.5% agar, and 97.5% distilled water.
[0027] 2) Construction of plasmid pCFC: with Edwardsiella tarda TX1 as a template, PCR with the following primers: F8 (5'- AGTA CT GCCACCATGGCACAAGTAATCAACA...
Embodiment 2
[0064] 1) DNA vaccine preparation:
[0065] The plasmid pPC2 obtained in step 1 of Example 1 was transformed into Escherichia coli and cultivated in the LB liquid medium containing 100ug / ml Ap for 18-24 hours. Company”, Beijing) to extract the plasmid pPC2 for use;
[0066] Then the Edwardsiella tarda DNA vaccine shown in the nucleotide sequence in the sequence table 1 SEQ ID No.1 obtained in Example 1 is transformed into Escherichia coli and cultivated in the LB liquid medium containing 100ug / ml Ap for 18- Within 24 hours, use an endotoxin-free plasmid extraction kit (purchased from "Tiangen Biochemical Technology Co., Ltd.", Beijing) to extract the Edwardsiella tarda DNA vaccine shown in the base sequence in Sequence Table 1 SEQ ID No.1, and wait until use.
[0067] The above-mentioned obtained plasmid pPC2 and the Edwardsiella tarda DNA vaccine shown in the base sequence in Sequence Table 1 SEQ ID No.1 were dissolved in PBS respectively to a concentration of 200ug / ml, whi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com